BMC Cancer Journal Citation Rate 2026
1471-2407
BioMed Central
GB
Q1 Quartile Open Access Established Impact
About BMC Cancer
BMC Cancer (BC) is a peer-reviewed academic journal, published by BioMed Central in GB, catalogued under ISSN 1471-2407. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 3.29 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2195 USD.
BMC Cancer Citation Rate 2026 — In Context
BMC Cancer has a 2025 2-Year Citation Rate (OpenAlex) of 3.29, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, BMC Cancer makes all articles freely available to readers for an Article Processing Charge of approximately $2195 USD.
Researchers looking to publish in BMC Cancer should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare BMC Cancer against similar journals in the field, use our journal comparison tool.
Submission Tips for BMC Cancer
- Budget $2195 for the Article Processing Charge. Check if your institution or funder covers OA fees.
| ISSN (Print) | 1471-2407 |
|---|---|
| Publisher | BioMed Central |
| Country | United Kingdom |
| APC / Cost | $2195 USD |
In-depth profile & metrics
BMC Cancer is published by BioMed Central and based in United Kingdom. It publishes open access with an article-processing charge of USD 2195.
BMC Cancer is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 3.295.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about BMC Cancer
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 3.295 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Significance of nodal yield after rectal resection in the TNT era: does count matter?
L. V. O’Connell, N. Murnaghan, A. O’Brien • 2026
-
Azvudine for the treatment of cancer patients with COVID-19: a multicenter, real-world, retrospective, cohort study
Lei Li, Wenjie Liu, Ling WANG • 2026
-
Diagnostic accuracy of an AI-based pathologic response assessment in locally advanced non-small cell lung cancer after neoadjuvant chemo-immunotherapy
Kichang Lee, Haenara Shin, Jungyoon Ohn • 2026
-
Therapeutic efficacy of cancer stem cell-based vaccine in colorectal murine model: reduced tumor growth and prolonged survival
Farideh Hashemi, Masoumeh Dehghan Manshadi, Sadegh Safaei • 2026
-
Nonadherence to changing guidelines in early breast cancer over two decades
Annikki Aromaa‐Häyhä, Päivi Auvinen, Nea Malila • 2026
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S192926780
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.